PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

3 hedge funds and large institutions have $3.59K invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$36

Top Sellers

1
-$18.7K
2
-$18.4K
3
-$14.7K
4
Citadel Advisors
Citadel Advisors
Florida
-$12.1K
5
Millennium Management
Millennium Management
New York
-$8.81K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2K
2
$1.56K
3
$36
4
–
5
–
6
–
7
–
8
–
9
–